X-group (possible homology)

7568 BRCT domain

Ligands and drugs

2,619
Member domains
124
with ligand contacts (≤ 4 Å)
4.7% of members
114
with DrugDomain annotations
4.4% of members
73
with a DrugBank compound
2.8% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

12
Proteins with classified ligands
3
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds75.81.21×q = 0.65
Organosulfur compounds20.28.22×not tested
Homogeneous non-metal compounds82.63.14×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB02189—2',3'-Dideoxyadenosine triphosphate1

Most frequently bound compounds

PDB ligandNameDomains in contact
CLCHLORIDE ION21
NImetalNICKEL (II) ION9
MGmetalMAGNESIUM ION7
COmetalCOBALT (II) ION4
IODIODIDE ION3
NAmetalSODIUM ION3
PRmetalPRASEODYMIUM ION3
SCNTHIOCYANATE ION3
CAmetalCALCIUM ION2
UNXUNKNOWN ATOM OR ION2
BRBROMIDE ION1
KmetalPOTASSIUM ION1
NMNBETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE1